We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+13.94%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$22.7B
AUM Growth
+$6.91B
(+44%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
20.03%
Top 10 Holdings %
Top 10 Hldgs %
42.56%
Holding
3,800
New
1,351
Increased
647
Reduced
509
Closed
1,292
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.95B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$848M |
| 3 |
Applovin
APP
|
+$243M |
| 4 |
AZEK
The AZEK Co
AZEK
|
+$142M |
| 5 |
Thomson Reuters
TRI
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$443M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$430M |
| 3 |
Shopify
SHOP
|
+$320M |
| 4 |
Flutter Entertainment
FLUT
|
+$240M |
| 5 |
Gilead Sciences
GILD
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.27% |
| 2 | Industrials | 7.89% |
| 3 | Technology | 6.89% |
| 4 | Healthcare | 4.69% |
| 5 | Communication Services | 4.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Alto Ingredients
ALTO
$340M
| $42K | ﹤0.01% |
+37,334
| New | +$35.8K |
|
|
OLOX
2327
Olenox Industries
OLOX
$4.5M
| $42K | ﹤0.01% |
+102
| New | +$38.9K |
|
2328
Catheter Precision
VTAK
$1.01M
| $42K | ﹤0.01% |
+9,148
| New | +$49.5K |
|
|
VIVO
2329
VivoPower PLC
VIVO
$124M
| $42K | ﹤0.01% |
+10,441
| New | +$44.6K |
|
2330
LiveOne
LVO
$58.2M
| $41K | ﹤0.01% |
+5,458
| New | +$40.6K |
|
2331
NeuroSense Therapeutics
NRSN
$18M
| $41K | ﹤0.01% |
+21,694
| New | +$31.4K |
|
|
OGG
2332
Osisko Gold Group Inc.
OGG
$853M
| $41K | ﹤0.01% |
+19,334
| New | +$35.8K |
|
|
API
2333
Agora
API
$377M
| $40K | ﹤0.01% |
+10,525
| New | +$36.7K |
|
2334
FingerMotion
FNGR
$18.1M
| $40K | ﹤0.01% |
+19,739
| New | +$48.4K |
|
|
MIN
2335
Aberdeen Intermediate Income Fund
MIN
$278M
| $40K | ﹤0.01% |
+14,965
| New | +$40K |
|
2336
Ovid Therapeutics
OVID
$491M
| $40K | ﹤0.01% |
123,316
+97,724
| +382% | +$29.4K |
|
|
PIM
2337
Franklin Master Intermediate Income Trust
PIM
$151M
| $40K | ﹤0.01% |
+11,988
| New | +$39.6K |
|
|
AUC
2338
ATIF Holdings
AUC
$72.2M
| $39K | ﹤0.01% |
+7,096
| New | +$102K |
|
2339
Actinium Pharmaceuticals
ATNM
$25M
| $38K | ﹤0.01% |
+27,476
| New | +$41.1K |
|
2340
Fuel Tech
FTEK
$43.7M
| $38K | ﹤0.01% |
+15,112
| New | +$21.6K |
|
2341
Identive
INVE
$61.9M
| $38K | ﹤0.01% |
+11,671
| New | +$37.5K |
|
2342
Moving iMage Technologies
MITQ
$5.42M
| $37K | ﹤0.01% |
+58,072
| New | +$35K |
|
2343
Pliant Therapeutics
PLRX
$65M
| $37K | ﹤0.01% |
+32,475
| New | +$45.9K |
|
|
ENGS
2344
Energys Group
ENGS
$85.3M
| $37K | ﹤0.01% |
+21,552
| New | +$85.9K |
|
2345
Acumen Pharmaceuticals
ABOS
$176M
| $36K | ﹤0.01% |
+31,427
| New | +$33.8K |
|
2346
Comtech Telecommunications
CMTL
$51.8M
| $36K | ﹤0.01% |
+14,890
| New | +$26.8K |
|
2347
Telomir Pharmaceuticals
TELO
$79.8M
| $36K | ﹤0.01% |
+28,889
| New | +$66.8K |
|
2348
Baosheng Media Group
BAOS
$999K
| $35K | ﹤0.01% |
12,887
+1,410
| +12% | +$3.4K |
|
2349
Coherus Oncology
CHRS
$196M
| $35K | ﹤0.01% |
+48,778
| New | +$42.1K |
|
|
OIO
2350
OIO Group
OIO
$640M
| $35K | ﹤0.01% |
3,709
-4,909
| -57% | -$34.1K |
|
Similar funds
DB
HRT Financial's Q2 2025 Portfolio in Review
As of Q2 2025, HRT Financial held 3,800 positions worth $22.7B, up 44% from $15.8B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
HRT Financial deployed $4.55B of net new capital in Q2 2025, opening 1,351 new positions and adding to 647 existing holdings. Its largest new stake was The AZEK Co: 2,834,659 shares worth $154M.
By sector, the portfolio is most concentrated in Financials at 8.3% of assets, down from 8.3% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $430M trimmed.
- HRT Financial's largest Q2 2025 buy was The AZEK Co: 2,834,659 shares worth $154M.
- HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $1.95B increase.
- HRT Financial's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $430M.
- HRT Financial fully exited Broadcom in Q2 2025, selling an estimated $443M.
- HRT Financial's ten largest holdings make up 43% of its $22.7B portfolio in Q2 2025.
- HRT Financial opened 1,351 new positions and closed 1,292 in Q2 2025.
- HRT Financial's portfolio value rose 44% quarter-over-quarter to $22.7B.
Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.